CDH1 and cancer: Tissue microarray analysis from 50 patients with head and neck cancer showed that 40% of these cancers expressed the transcription factor, Twist, which is known to be activated in several metastatic tumors resulting in the reduction of E-cadherin and an EMT phenotype associated with reduced differentiation status and lymph node metastasis [170].